BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim

This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesiz...

June 30, 2021 | News

Samsung Biologics continues to leverage remote audits and regulatory inspections

Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessments Recently hosted EMA for 6 PAIs simultaneously using ...

June 24, 2021 | News

Vibalogics to expand cGMP manufacturing capacity for viral vectors

The investment by the CDMO, which specializes in the production of oncolytic viruses, viral vector vaccines and viral vector gene therapy products includes...

June 17, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

June 16, 2021 | News

WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates

Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...

June 10, 2021 | News

iResearch Atlanta welcomes new investigators and expands its operations

iResearch Atlanta welcomes new investigators and expands its operations to serve more patients in phase I-IV clinical trials, the ability to cont...

June 10, 2021 | News

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization, signed a strategic partnership with KAHR...

June 03, 2021 | News

Moderna, Thermo Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered i...

June 02, 2021 | News

Samsung Biologics to add mRNA vaccine DS production capability

Samsung Biologics, a global leading CDMO, will add mRNA vaccine DS production capability to its existing facility by the first half of 2022 The addition...

June 01, 2021 | News

WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership

Per the agreement, WuXi Biologics, as the exclusive CDMO partner will provide biologics development and cGMP manufacturing services for OncoC4’s prod...

May 27, 2021 | News

Vetter Once Again Wins Axia Best Managed Companies Award

§ Internationally renowned seal of quality for exemplary corporate management § Positive assessment of strategy, innovatio...

May 26, 2021 | News

Moderna and South Korea Explore Collaboration on mRNA Vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Unde...

May 24, 2021 | News

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine

Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leadin...

May 24, 2021 | News

WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services

Per the terms of the joint venture agreement, WuXi Biologics and WuXi STA will make capital contributions of USD120 million and USD8...

May 14, 2021 | News

Stay Connected